| Get the NRC Update Newsletter! |
 | |
New Topics
Acute Coronary Syndrome in Women Endotoxemia Leukemia and Diet Nutrition in Pregnancy Oral Intake During Labor Riboflavin Vitamin C (Ascorbic Acid) Vitamin E Yellow Fever Vaccine (YF-VAX)
And much more!
|
|
|
Nursing Reference Center Peer Review
| Become a peer reviewer!
|
|
|
| Welcome! | |
Welcome back to our free evidence-based Nursing Reference Center Update. We will periodically send news on the latest evidence in nursing. Please share this with your colleagues, students, practitioners and others who would appreciate awareness of this information.
|
| Nursing Reference Center in Daily Practice | |
Caring for Patients: Complicated Grief
The clinic nurse is assigned to Craig, a 51-year-old man who made an appointment because his father passed away 14 months ago, and he is still having a hard time believing that his father has died.
Before introducing herself to Craig, the clinic nurse consults the Nursing Reference Center, searching for complicated grief and locates the Evidence Based Care Sheet, "Complicated Grief." The nurse reviews what she can do to help Craig come to terms with his father's death.
The nurse talks with Craig, and asks him open-ended questions about how he is doing. The nurse requests a referral to a mental health clinician, and discusses the range of emotions that people often feel after ther death of a loved one. The nurse encourages the patient to seek out family and social support, and to join a support group.
In addition, the nurse explains to Craig that it is important to get enough rest, to eat a well-balanced diet, and to make time for regular exercise and for relaxation daily.
After their discussion, Craig feels supported and glad to know about the array of supports available to help him cope with his father's death.
Note: The above referenced Evidence-based Care Sheet is freely accessible to all readers of the Nursing Reference Center Update. |
| Quick Overview | |
Sunburn
Summer is upon us, and every nurse has cared for a patient who has gotten a bad sunburn while participating in outdoor summertime recreation. Individuals are most susceptible to sunburn from 10 a.m. to 4 p.m.
Before assessing a patient who has sunburn, the nurse refers to the Nursing Reference Center Quick Lesson article, "Sunburn" and learns about the signs and symptoms of sunburn. Later, during the patient assessment the nurse assesses the patient's skin for redness and tenderness, and for blistering, chills, nausea, and rash.
Nurses are in a unique position to educate patients about preventing future sunburn. The nurse encourages the patient to wear sunscreen that protects against ultraviolet (UV) rays, to limit sun exposure, and to wear clothing and sunglasses that protect skin from the sun's rays.
Please login to your Nursing Reference Center subscription to read the Quick Lesson on "Sunburn."
|
Evidence-based Content Update | |
New Drug Released for the Treatment of Unresectable or Metastatic Malignant Melanoma
Ipilimumab (Yervoy) is a new drug used for the treatment of unresectable or metastatic malignant melanoma, a skin cancer whose incidence is increasing at the second highest rate of all cancers in the United States. The nurse refers to the Nursing Reference Center (NRC) Quick Lesson article, "Melanoma" for more information about the disease.
Nursing monitoring and assessment of patients being treated with ipilimumab is critical because the medication, a monoclonal antibody (MAB) that utilizes the patient's immune system to attack cancer cells, can cause severe and fatal immune-mediated adverse reactions. Nurses administering ipilimumab should ask patients how they are feeling, if they have experienced any changes in their vision, sexual drive, any gastrointestinal disturbances, skin rashes or skin yellowing, and if they have experienced any weakness or inability to complete activities of daily living (ADLs).
The nurse refers to the NRC Drug Quick Lesson article, "Ipilimumab (Yervoy)" for more information about the drug and how it is an effective treatment for unresectable or metastatic malignant melanoma.
With the growing presence of MAB drugs on the market worldwide, all nurses need to be knowledgeable about how to appropriately monitor and assess a patient who is undergoing MAB treatment.
|
|
|
|
|
